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Abstract
Background: Osteoarthritis (OA) of the knee joint is a degenerative process resulting in cartilage loss. Recent
evidence suggests that OA is not merely a disease of cartilage but a disease of the entire knee joint and that
inflammation may play an important role. OA has been associated with vitamin D deficiency. Vitamin D as an
immunomodulator and anti-inflammatory agent may attenuate inflammation in the knee. The aim of this study
was to assess the anti-inflammatory effect of vitamin D on inflammation in the knee.
Methods: This study was conducted with 13 microswine on a high cholesterol diet categorized into three groups
of vitamin D-deficient, vitamin D-sufficient, and vitamin D supplementation. After 1 year, microswine were killed,
and their knee joint tissues were harvested. Histological and immunofluorescence studies were carried out on the
tissue specimens to evaluate the effect of vitamin D status.
Results: Histological and immunofluorescence studies of the knee joint tissues showed (1) increased inflammation
in the knee joint tissues, (2) fatty infiltration in quadriceps muscle, patellar tendon, and collateral ligaments, and
(3) chondrocyte clustering in the vitamin D-deficient and vitamin D-sufficient groups compared with the vitamin D
supplementation group. Architectural distortion of the quadriceps muscle, patellar tendon, and collateral ligaments
was also seen in the areas of inflammatory foci and fatty infiltration in the vitamin D-deficient group.
Conclusions: Decreased inflammation and fatty infiltration in the vitamin D supplementation group suggest the
potential role of vitamin D in attenuating inflammation and fatty infiltration as well as in protecting the architecture
of the tissue in the knee joint.
Keywords: Osteoarthritis, Vitamin D deficiency, Cartilage loss, Inflammation, Fatty infiltration, Vitamin D
supplementation, Inflammation attenuation
Background
Inflammation of the joint accompanied with pain and
swelling is a major problem leading to joint damage. This
inflammation is accompanied with loss of joint flexibility
and range of motion, resulting in physical disability and
limitation of movement. Among the hand, hip, and knee
joints, knee joint arthritis is the most common form of
arthritis [1]. Osteoarthritis (OA) of the knee joint is a de-
generative joint disease that is the foremost cause of dis-
ability in the elderly population in the United States [2].
OA is characterized by an imbalance between degenera-
tive and regenerative processes, resulting in cartilage loss
[3]. Although the pathogenesis of cartilage degeneration is
still unclear, there is evidence which suggests that cartilage
damage is due to periarticular bone resorption and
sclerosis during subchondral bone remodeling. This
subchondral bone remodeling response may be slowed by
low levels of vitamin D, resulting in bone thickening,
osteophyte formation, and resultant cartilage damage
[4, 5]. Therefore, low levels of vitamin D may affect struc-
tural changes of the knee joint [3]. OA affects all the knee
joint tissues, including cartilage, muscle [2, 6], tendon, liga-
ment, and subchondral bone, and these changes play an
important role in the pathogenesis of OA [7]. Vitamin D
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influences the state of these articular structures by acting
through vitamin D receptors (VDRs). VDR polymorphism
has been associated with OA, and therefore vitamin D may
play an important role in OA pathogenesis [8–10].
Vitamin D deficiency is common worldwide [11].
Vitamin D deficiency has been associated with many
musculoskeletal diseases, such as muscle weakness, rick-
ets, osteomalacia, osteopenia, and osteoporosis, as well
as increased risk of fracture and muscle weakness [12].
The important role of vitamin D in bone mineralization,
remodeling, and maintenance is well known, but the role
of vitamin D in the pathogenesis of OA is yet to be
defined [4]. Low levels of vitamin D are associated with
progression and increased prevalence of OA [13–16].
Many studies support the beneficial role of vitamin D in
OA [17, 18], but this is controversial [19, 20]. Low levels
of vitamin D have also been associated with an increased
incidence of inflammation [21, 22]. Recent evidence
suggests a potential role of inflammation in OA pathogen-
esis [23, 24], and vitamin D as an immunomodulatory and
anti-inflammatory agent may attenuate inflammation in
the knee.
Macrophages are potent modulators of inflammation
and, as sentinels of the innate immune system, are involved
in the inflammatory response. OA is a wear-and-tear
disease, and wear particles also stimulate a macrophage re-
sponse [25]. Macrophages and macrophage-produced cyto-
kines play a potential role in the pathogenesis of OA [26].
Thus, inflammatory mediators or markers expressed on
macrophages may play a role in the pathogenesis of OA.
Triggering receptor expressed on myeloid cells (TREM)-1
is a recently discovered amplifier of inflammation ex-
pressed on monocytes and/or macrophages and neutro-
phils, and TREM-2, an anti-inflammatory marker secreted
from macrophages and dendritic and microglial cells,
plays a key role in many inflammatory diseases [27–29].
TREM-1 plays a potential role in the pathogenesis of
rheumatoid arthritis [30]. However, the role of TREM-1
and TREM-2 in OA is largely unknown. Further, early
innate response due to trauma to the joint results in
secretion of adiponectin and leptin by adipose tissue
[7, 31–33]. The effect of vitamin D status on release of
these adipokines in inflamed knee joints is largely un-
known. Because vitamin D is an immunomodulatory and
anti-inflammatory agent, vitamin D supplementation may
affect the expression of TREM-1, TREM-2, adiponectin,
and leptin, but this association is currently not well defined.
Vitamin D deficiency and decreased expression of
VDR are associated with increased inflammation of
epicardial fat, and vitamin D supplementation reduces
this inflammation [34]. Further, hyperlipidemia and high
fructose are also instigators of inflammation [34, 35].
While studying the effect of vitamin D status on the
development of atherosclerotic lesions in the coronary
arteries of swine fed a high-cholesterol and high-fat diet,
we observed increased inflammation in the knee of the
vitamin D-deficient swine. Therefore, we planned to evalu-
ate the effect of vitamin D status (deficient, sufficient, and
supplemented) on inflammation, TREMs, adiponectin, lep-
tin, and change in the histology of the knee joint tissues in
these microswine. We hypothesized that vitamin D supple-
mentation should decrease inflammation in the knee joint
tissue. The purpose of this study was to evaluate the bene-
ficial immunomodulatory and anti-inflammatory roles of
vitamin D in attenuating inflammation in the knee.
Methods
Porcine model
This study was conducted using Yucatan female micro-
swine [36, 37]. In this study, 11 microswine were fed a
pelleted, high-cholesterol diet (Teklad Miniswine Diet;
Envigo, Indianapolis, IN, USA) with 17.4 % protein,
45.2 % carbohydrate, and 10.0 % fat by weight. Of the
total kilocalories derived from the diet, 20.4 % of the
kilocalories were from protein, 53.1 % were from carbo-
hydrate, and 26.4 % were from fat. Two swine were fed a
pelleted, high-fructose diet (1.5 IU/g vitamin D, 17.6 %
fructose, 4 % cholesterol, 1.5 % sodium cholate; Teklad
Miniswine Diet TD-150253) with 17.4 % protein, 46.8 %
carbohydrate, and 10.0 % fat by weight. Of the total
kilocalories derived from the diet, 20.1 % of the kilo-
calories were from protein, 54.0 % were from carbo-
hydrate, and 26.0 % were from fat. The pelleted diet
was either vitamin D-deficient (TD-150251), vitamin D-
sufficient (TD-150250; 1.5 IU/g vitamin D, 4.5 % hydroge-
nated vegetable oil, 4 % cholesterol, 1.5 % sodium cholate)
with 1500 IU/day of vitamin D3, or supplemented (TD-
150252; 5 IU/g vitamin D, 4.5 % hydrogenated vegetable
oil, 4 % cholesterol, 1.5 % sodium cholate) with 5000 IU/
day of vitamin D3. On the basis of our previous experience
and other studies, vitamin D3 supplementation with
1500 IU/day for the vitamin D-sufficient group or
5000 IU/day for the vitamin D-supplemented group was
added to achieve normal (21–29 ng/ml) or supplemented
serum levels of vitamin D in microswine [33, 38, 39].
Serum 25(OH)D levels were measured regularly. Blood
serum levels of vitamin D were measured and recorded.
The swine were placed into three respective categories
based upon their 25(OH)D levels. The 25(OH)D-level pa-
rameters used for the classification were as follows: Levels
in vitamin D-deficient (VDDef) swine were ≤20 ng/ml;
levels in vitamin D-sufficient (VDSuff ) swine were
30–44 ng/ml; and levels in vitamin D-supplemented
(VDSupp) swine were >44 ng/ml. Five swine were in the
VDDef group, 5 were in the VDSuff group, and 3 were in
the VDSupp group, for a total of 13 swine in this study.
After 1 year of being fed the diet, the microswine were
killed, and knee joint tissues were collected.
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Tissue acquisition
The knee joint tissues (suprapatellar fat, quadriceps
muscle, articular cartilage of tibial tuberosity, patellar
tendon, collateral ligaments, medial and lateral menisci,
infrapatellar fat pad, and synovial membrane) were har-
vested quickly after the swine were killed. Then the tis-
sues were transported to a laboratory and fixed in 4 %
formalin buffer for 24 h. Each specimen was transversely
sectioned at 2 mm, processed in a Tissue-Tek VIP tissue
processor (Sakura Finetek, Torrance, CA, USA), and
embedded in paraffin. Thin sections (5 μm) were cut using
a microtome (Leica Biosystems, Buffalo Grove, IL, USA)
and subsequently placed on slides for hematoxylin and
eosin (H&E) staining and immunofluorescence evaluation.
Hematoxylin and eosin staining of specimens
All the knee joint tissues were stained with H&E follow-
ing the manufacturer’s standard protocol (Newcomer
Supply, Middleton, WI, USA). Stained slides were ana-
lyzed for the presence or absence of inflammation and
fatty infiltration. All the slides were reviewed by a board-
certified pathologist. All the images were scanned at × 20
magnification using an Olympus BX51inverted micro-
scope (Olympus Scientific Solutions, Waltham, MA, USA)
with a scale bar of 200 μm. The average adipocyte size in
infra- and suprapatellar fat was calculated by selecting 15
random adipocytes in the different swine groups in each
category using ImageJ software (National Institutes of
Health [NIH], Bethesda, MD, USA). Chondrocyte count-
ing was done using three high-power field images, and the
average number of clustered chondrocytes to total
chondrocytes per high-power field in each group was
calculated. Areas of fatty infiltration were scanned, and
fatty infiltration within the matrix of muscle, tendon, and
ligament was calculated by measuring the area of all
adipocytes present in the matrix followed by calculating
the percentage of infiltration area per field.
Histological analysis for proteoglycans, collagens, and
matrix metalloproteinases
Tissue sections were stained with Alcian blue and
Safranin-O Fast Green staining for analysis of the cartil-
age mucosubstance content in VDDef, VDSuff, and
VDSupp swine cartilage. The stained slides were scanned
by using an Olympus microscope at × 40 magnification.
The results of the stained slides were graded in a blinded
manner by a board-certified pathologist on a scale of
0–5 where 0 =minimal blue staining, 1 = very weak blue
staining, 2 = weak blue staining, 3 =moderate blue stain-
ing, 4 = strong blue staining, and 5 = very strong blue
staining for Alcian blue, and on a scale of 0–5 where
0 = minimal orange-red staining, 1 = very weak orange-red
staining, 2 = weak orange-red staining, 3 =moderate or-
ange-red staining, 4 = strong orange-red staining, and
5 = very strong orange-red staining for Safranin-O
Fast Green staining [40].
Additionally, the tissue sections were examined by
modified Russell-Movat pentachrome staining to assess
the collagen and mucosubstance content of cartilage in
VDDef, VDSuff, and VDSupp swine. The slides were
double-checked by the pathologist in a blinded manner.
The stained slides were scanned with an Olympus
microscope at × 20 magnification and graded on a scale
of 0–5 for collagen (yellow staining) and mucinous sub-
stance (blue-green staining), where 0 =minimal yellow/
blue-green staining, 1 = very weak yellow/blue-green stain-
ing, 2 = weak yellow/blue-green staining, 3 =moderate
yellow/blue-green staining, 4 = strong yellow/blue-green
staining, and 5 = very strong yellow/blue-green staining.
The tissue sections were also subjected to immunohisto-
chemical (IHC) staining for aggrecans and proteoglycans
(aggrecans, decorins, and versicans). The IHC staining was
conducted as per the standard protocol in our laboratory.
Antigoat aggrecan (sc-25674; Santa Cruz Biotechnology,
Dallas, TX, USA) for aggrecans in a 1:50 dilution and anti-
mouse decorin (6D6-c; Developmental Studies Hybridoma
Bank, Iowa City, IA, USA) and antimouse versican
(12C5-c; Developmental Studies Hybridoma Bank) anti-
bodies in a 1:100 dilution were used as the primary anti-
bodies. A biotinylated secondary antibody was used, and
diaminobenzidine was used as a fluorochrome to develop
the slides. The slides were counterstained with hematoxylin
to stain the nuclei. The slides were blindly checked by the
pathologist. The slides were scanned at × 40 magnification
with an Olympus microscope, and the total number of
immunopositive cells for aggrecans, decorins, and versi-
cans were counted on three different images for all tissues
using ImageJ software. Cell density per square millimeter
was calculated in the VDDef, VDSuff, and VDSupp groups.
Immunofluorescence studies
Deparaffinization, rehydration, and antigen retrieval were
performed prior to immunostaining. Immunofluorescent
staining was done as per the standard protocol in our
laboratory. As primary antibodies, we used rabbit anti-
TREM-1 (PAA213Po01; Cloud-Clone Corp., Houston, TX,
USA), rabbit anti-TREM-2 (bs-2723R; Bioss Inc., Woburn,
MA, USA), and mouse anti-CD14 (ab182032; Abcam,
Cambridge, MA, USA) for macrophages, mouse antiadipo-
nectin (ab22554; Abcam), and rabbit antileptin (ab16227;
Abcam) at 1:200 dilution, as well as mouse anti-neutrophil
elastase (sc-53388; Santa Cruz Biotechnology) at 1:50
dilution. Alexa Fluor 594-conjugated (red) and Alexa
Fluor 488-conjugated (green) secondary antibodies (Life
Technologies, Carlsbad, CA, USA) at 1:500 dilution were
used. The slides were counterstained with 4′,6-diamidino-
2-phenylindole (DAPI) to stain nuclei. Negative controls
were run by using an isotype antibody for each
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fluorochrome. Immunofluorescence microscopy was car-
ried out with an Olympus BX51 inverted fluorescence
microscope. The images were scanned at × 20 magnifica-
tion and were reviewed by a board-certified pathologist.
The mean fluorescence intensity (MFI) for TREM-1,
TREM-2, adiponectin, and leptin was quantified by using
ImageJ software. Two images from each swine in each
group were taken for the measurement of MFI. The num-
ber of TREM-2 and CD-14 dual-positive cells was counted
in five high-power fields for each tissue in all swine, and
the average number of TREM-2 and CD-14 dual-positive
cells per square millimeter was calculated for each group.
The analysis for the collagen types I, II, and III content
in the VDDef, VDSuff, and VDSupp swine was carried
out by immunofluorescent staining. Antirabbit collagen I
(sc-30136; Santa Cruz Biotechnology), antigoat collagen
II (sc-389924; Santa Cruz Biotechnology), and antirabbit
collagen III (sc-28888; Santa Cruz Biotechnology) anti-
bodies in 1:50 dilution were used as primary antibodies.
Alexa Fluor 594-conjugated (red) and Alexa Fluor 488-
conjugated (green) secondary antibodies (Life Technologies)
at 1:500 dilution were used. DAPI was used to stain the
nuclei. The stained slides were blindly double-checked by
the pathologist. MFI for collagen II was calculated using
three separate images for all swine in each group. ImageJ
software was used to analyze the MFI. Average MFI was
calculated for the three different groups of swine.
The analysis for the matrix metalloproteinases (MMPs)
in the VDDef, VDSuff, and VDsupp swine was also carried
out by immunofluorescent staining. Antigoat MMP-1
(sc-21731; Santa Cruz Biotechnology), antimouse MMP-2
(sc-53630; Santa Cruz Biotechnology), antimouse MMP-8
(sc-101450; Santa Cruz Biotechnology), antigoat MMP-9
(sc-6840; Santa Cruz Biotechnology), and antimouse
MMP-13 (sc-101564; Santa Cruz Biotechnology) anti-
bodies in a 1:50 dilution were used as primary antibodies.
Alexa Fluor 594-conjugated (red) and Alexa Fluor 488-
conjugated (green) secondary antibodies (Life Technolo-
gies) at 1:500 dilution were used. DAPI was used to stain
the nuclei. The stained slides were blindly double-checked
by the pathologist. MFI for MMP-9 was calculated using
the three separate images for all swine in each group. Ima-
geJ software was used to analyze the MFI. Average MFI
was calculated for the three different groups of swine.
Analysis of the vitamin D status with TREM-2 MFI,
macrophage density, chondrocyte density and clustering,
and adipocyte area
To correlate vitamin D status with various parameters of
interest, correlation analysis was performed. The average
values for the macrophage density in the VDDef, VDSuff,
and VDSupp groups were converted into logarithm
values to fit them in the range of values for other param-
eters (to fit them into a graph).
Statistical analysis
Results are presented as mean ± SD for each parameter.
The Wilcoxon two-samples test was used for statistical
analysis of the significance of differences between the




The serum levels of vitamin D at the beginning of the
study were <15 ng/ml in the VDDef group, 17.53 ±
1.13 ng/ml in the VDSuff group, and 31.93 ± 3.04 ng/ml
in the VDSupp group. The experimental diets were
started when the swine were at the age of 6 months.
After 1 year of feeding the swine the experimental diet,
the mean serum 25(OH)D levels were 8.1 ± 1.13 ng/ml
in the VDDef group, 24.01 ± 0.72 ng/ml in the VDSuff
group, and 52.58 ± 5.68 ng/ml in the VDSupp group.
The corresponding average levels of serum parathyroid
hormone were 38.57 ± 5.75 ng/ml, 13.03 ± 3.23 ng/ml,
and 8.52 ± 2.19 ng/ml, respectively; serum calcium,
8.60 ± 0.78 ng/ml, 10.02 ± 0.22 ng/ml, and 9.7 ± 0.05 ng/ml,
respectively; and serum cholesterol, 512.01 ± 56.9 ng/ml,
551.75 ± 45.03 ng/ml, and 461 ± 43.08 ng/ml, respectively.
The corresponding average weights at the time the
animals were killed were 95.96 ± 4.53 lb, 112.24 ± 6.23 lb,
128.11 ± 13.97 lb, respectively (see Additional file 1).
Increased inflammation in vitamin D-deficient group
Microscopic analysis of H&E-stained sections of infrapa-
tellar fat (Fig. 1a, b, c), quadriceps muscle (Fig. 1d, e, f ),
patellar tendon (Fig. 1j, k, l), collateral ligament
(Fig. 1m, n, o), meniscal cartilage (Fig. 1p, q, r), suprapatel-
lar fat (Fig. 1s, t, u), and synovial membrane (Fig. 1v, w, x)
revealed increased inflammation in the VDDef group
compared with the VDSuff and VDSupp groups. The in-
flammation in the VDSuff group was higher than that in
the VDSupp group. In synovial membrane, there was mild
inflammation and mild hyperplasia in the VDDef group,
while the VDSuff and VDSupp groups showed minimal
changes. Inflammation was defined on the basis of the
presence of macrophages and/or neutrophils in the tissue
matrix. Knee joint tissues in the VDDef group showed the
presence of many inflammatory cells along with the clus-
ter of inflammation (>4 inflammatory cells), while there
were only occasional or few inflammatory cells in the
VDSuff and VDSupp groups (see Additional file 2).
Increased fatty infiltration in vitamin D-deficient group
Histological analysis of H&E-stained sections of muscle,
tendon, and ligament showed increased fatty infiltration
in the VDDef group (Fig. 2a, d, g) compared with the
VDSuff (Fig. 2b, e, h) and VDSupp (Fig. 2c, f, i) groups.
There was minimal fatty infiltration in the VDSuff
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Fig. 1 Hematoxylin and eosin (H&E) staining of infrapatellar fat, quadriceps muscle, articular cartilage, patellar tendon, collateral ligament, meniscal
cartilage, suprapatellar fat, and synovial membrane. H&E staining shows the histology and inflammation in the vitamin D-deficient (VDDef), vitamin
D-sufficient (VDSuff), and vitamin D-supplemented (VDSupp) group infrapatellar fat (a, b, c), muscle (d, e, f), articular cartilage (g, h, i), tendon (j, k, l),
ligament (m, n, o), menisci (p, q, r), suprapatellar fat (s, t, u), and synovial membrane (v, w, x). Arrows indicate the presence of inflammatory cells in
the tissue. These are the representative images of five swine each in the VDDef and VDSuff groups and three swine in the VDSupp group
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group, and no fatty infiltration was observed in the
VDSupp group (see Additional file 2). Fatty infiltration
was defined as the presence of adipocytes between
muscle, tendon, and ligament fibers (i.e., not simply next
to the structure, but interspersed within the structure).
The percentage of fatty infiltration per field was
calculated in the VDDef, VDSuff, and VDSupp groups
(Fig. 2s). The presence of adipocytes interspersed within
the structure was further confirmed by Oil Red O stain-
ing and immunopositivity for adiponectin around the
adipocyte (data not shown).
Increased chondrocyte clustering in vitamin D-deficient
group
Histological analysis of articular cartilage in the VDDef,
VDSuff, and VDSupp groups revealed increased chondro-
cyte clustering in the VDDef group compared with the
VDSuff and VDSupp groups (Fig. 2j, k) as well as in the
VDSuff group (Fig. 2k) compared with the VDSupp group
(Fig. 2l). Quantitation of chondrocytes per high-power
field showed that nearly 50 % of chondrocytes were
clustered in the VDDef and VDSuff groups, whereas only
3–4 % were clustered in the VDSupp group (Figs. 2t
and 3c) (see Additional file 1).
Increased adipocyte size in vitamin D-deficient group
Analysis of the average adipocyte area in suprapatellar
(Fig. 2m, n, o) and infrapatellar (Fig. 2p, q, r) fat pads re-
vealed significantly increased adipocyte size in the
VDDef group compared with the VDSuff and VDSupp
groups, as well as in the VDSuff group compared with
the VDSupp group (Fig. 2u).
Decreased expression of proteoglycans in
vitamin D-deficient group
Analysis of Alcian blue, Safranin-O Fast Green, and
modified Russell-Movat pentachrome staining and
immunohistochemistry for proteoglycans (aggrecans,
decorins, and versicans) showed decreased expression of
matrix substance and proteoglycans in the VDDef group
(Fig. 4a, d, g, j, m, p) compared with the VDSuff
(Fig. 4b, f, h k, n and q) and VDSupp (Fig. 4c, f, i, l, o, r)
Fig. 2 Hematoxylin and eosin (H&E) staining of quadriceps muscle, patellar tendon, collateral ligaments, articular cartilage, and infra- and suprapatellar fat
pads. H&E staining shows the fatty infiltration in the vitamin D-deficient (VDDef), vitamin D-sufficient (VDSuff), and vitamin D-supplemented (VDSupp)
groups: quadriceps muscle (a, b, c), patellar tendon (d, e, f), and collateral ligaments (g, h, i). Chondrocyte clustering (×40 original magnification) in the
VDDef and VDSuff groups compared with the VDSupp group (j, k, l), as well as the adipocyte area in infrapatellar (m, n, o) and suprapatellar fat pads
(p, q, r), is shown. The percentage of fatty infiltration per high-power field (s), average total and clustered chondrocytes (t), and average adipocyte area
(u) are graphed. Arrows indicate the presence of adipocytes within the matrix of the tissue and chondrocyte clustering. These are the representative
images of five swine each in the VDDef and VDSuff groups and three swine in the VDSupp group. Data are shown as mean ± SD. *p < 0.05, **p< 0.01
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groups. Comparison of the VDSuff group with the
VDSupp group revealed increased expression of proteo-
glycans in the VDSuff group compared with the VDSupp
group (Fig. 4). Proteoglycan and matrix substance ex-
pression in the VDSuff group swine was nonuniform,
whereas the expression in the VDSupp group was uniform
(Fig. 4, Table 1).
Increased leptin and decreased adiponectin expression in
vitamin D-deficient swine
Immunofluorescence studies of infrapatellar and supra-
patellar fat revealed greater immunoreactivity for leptin
and lesser immunoreactivity for adiponectin in the
VDDef group (Fig. 5a, j; Additional file 3a, j) than in the
VDSuff (Fig. 5d, m; Additional file 3d, m) and VDSupp
(Fig. 5g, p; Additional file 3 g, p) groups. The MFI of lep-
tin was higher and that of adiponectin was lower in the
VDDef group than in the VDSuff and VDSupp groups
(Fig. 5s, t). The average adipocyte counts in infra- and
suprapatellar fat pads were higher in the VDDef group
than in the VDSuff and VDSupp groups, and they were
higher in the VDSuff group than in the VDSupp group
(Fig. 5s, t).
Increased expression of TREM-2 in vitamin D-sufficient
and vitamin D-supplemented groups
Immunofluorescence studies of articular cartilage
(Fig. 6a, e, i), synovial membrane (Fig. 6a, q, u),
Fig. 3 Analysis of changes in inflammation, fatty infiltration, adipocyte area, and chondrocyte clustering by vitamin D status in knee joint tissues.
a Macrophage density (per square millimeter, logarithm values), triggering receptor expressed on myeloid cells (TREM)-2 mean fluorescence
intensity (MFI), and adipocyte area (per square millimeter) in infrapatellar fat. b Macrophage density (per square millimeter), TREM-2 MFI, and fatty
infiltration (percentage of area, logarithm values) in muscle. c Macrophage density (per square millimeter, logarithm values), TREM-2 MFI, and chondrocyte
clustering (clustered/total chondrocytes, logarithm values) in articular cartilage. d Macrophage density (per square millimeter), TREM-2 MFI, and fatty
infiltration (percentage of area, logarithm values) in tendon. e Macrophage density (per square millimeter), TREM-2 MFI, and fatty infiltration (percentage
of area) in ligament. f Macrophage density (per square millimeter) and TREM-2 MFI in menisci. g Macrophage density (per square millimeter, logarithm
values), TREM-2 MFI, and adipocyte area (per square millimeter) in suprapatellar fat. h Macrophage density (per square millimeter, logarithm values) and
TREM-2 MFI in synovial membrane
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infrapatellar fat (see Additional file 4a, e, i), quadriceps
muscle (see Additional file 4m, q, u), patellar tendon (see
Additional file 5a, e, i), collateral ligaments (see Additional
file 5m, q, u), meniscal cartilage (see Additional file 6a, e, i),
and suprapatellar fat (see Additional file 6 m, q, u) re-
vealed higher immunoreactivity for TREM-2 in the
VDSupp group than in the VDSuff and VDDef groups and
in the VDSuff group than in the VDDef group (Fig. 3).
The MFI of TREM-2 was significantly higher (Fig. 7a) in
the VDSuff and VDSupp groups than in the VDDef group.
The colocalization of TREM-2 with macrophages was ob-
served more in the VDDef group than in the VDSuff and
VDSupp groups and in the VDSuff group than in the
VDSupp group. We found very minimal positivity for
TREM-1 in articular cartilage, tendon, ligament, and
suprapatellar fat (see Additional file 7a, e, i, m).
Decreased expression of collagen II and increased
expression of MMP-9 in vitamin D-deficient group
Immunofluorescent staining for collagen I, II, and III re-
vealed higher immunoreactivity of collagen II than for
collagen I and III in all cartilage tissues (see Additional
file 8a, d, g). The immunofluorescence studies for
collagen II revealed decreased immunoreactivity in the
Fig. 4 Alcian blue, Safranin-O Fast Green, modified Russell-Movat pentachrome, and immunohistochemical staining for matrix substance and
proteoglycans (aggrecans, decorins, and versicans). Alcian blue (a, b, c), Safranin-O Fast Green (d, e, f), modified Russel-Movat pentachrome
(g, h, i), aggrecans (j, k, l), decorins (m, n, o), and versicans (p, q, r) in the vitamin D-deficient (VDDef), vitamin D-sufficient (VDSuff), and vitamin
D-supplemented (VDSupp) groups of swine. These are the representative images of five swine each in the VDDef and VDSuff groups and three
swine in the VDSupp group
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VDDef group compared with the VDSuff and VDSupp
groups (Fig. 8a, d, g), and in the VDSuff group compared
with the VDSupp group (Fig. 8d, g). The immunofluores-
cence studies showed no immunoreactivity for MMP-1,
MMP-2, and MMP-13 (see Additional file 9a, d, m), very
minimal immunoreactivity for MMP-8 (see Additional
file 9g), and higher immunoreactivity for MMP-9 (see
Additional file 9j) in the VDDef, VDSuff, and VDSupp
groups. The immunoreactivity of MMP-9 was higher
in the VDDef group than in the VDSuff and VDSupp
groups (Fig. 8j, m, p) and in the VDSuff group than in the
VDSupp group (Fig. 8m, p). The MFI of collagen II
(Fig. 8s) and MMP-9 (Fig. 8t) was significantly higher in
the VDDef group than in the VDSuff and VDSupp groups
and in the VDSuff group than in the VDSupp group.
Increased number of macrophages in vitamin D-deficient
group
Dual-immunofluorescence studies of TREM-2 and
macrophage for suprapatellar and infrapatellar fat,
muscle, tendon, ligament, meniscal cartilage, articular
cartilage, and synovial membrane showed significantly
an increased number of macrophages in the VDDef
group compared with the VDSuff and VDSupp groups
(Fig. 3). Higher numbers of CD14+ cells were found
colocalized with TREM-2 in the VDDef group than in
the VDSuff and VDSupp groups (Fig. 7b). Fewer
macrophages colocalized with TREM-1 in articular car-
tilage, tendon, ligament, and suprapatellar fat in the
VDDef group were also observed (see Additional file 7).
Dual-immunofluorescence of TREM-1, TREM-2, and
neutrophils showed no positivity for neutrophil elastase,
suggesting the absence of neutrophils in the knee joint
tissues (data not shown).
Discussion
On the basis of microscopic analysis of H&E staining, com-
pared with the VDSupp group, in the VDDef and VDSuff
groups we found increased inflammation in knee joint
tissues; increased fatty infiltration in quadriceps muscle,
patellar tendon, and collateral ligaments; and increased
chondrocyte clustering. These findings were further sup-
ported by immunofluorescence studies. Histological ana-
lysis of the matrix substance, proteoglycans, and collagens
showed increased cartilage matrix loss in the VDDef group
compared with the VDSuff and VDSupp groups and in the
VDSuff group compared with the VDSupp group. There
was increased expression of MMP-9 in the VDDef group
compared with the VDSuff and VDSupp groups and in the
VDSuff group compared with the VDSupp group. The very
weak light blue staining in VDDef group compared with
VDSuff and VDSupp group, as well as the moderate blue
staining in the VDSuff group compared with very strong
blue staining in the VDSupp group by Alcian blue staining,
Table 1 Histological analysis of matrix substance and proteoglycans (aggrecan, decorin, and versican) for collagen loss in knee
cartilage of VDDef, VDSuff, and VDSupp swine





Aggrecan+ cells/mm2 Decorin+ cells/mm2 Versican+ cells/mm2
VDDef
1 3 0 3/4 4.72 ± 0.84 12.16 ± 1.39 5.06 ± 1.23
2 1 0 2/4 0 0 0
3 2 0 3/3 0 0 0
4 2 2 3/4 18.51 ± 4.42 11.29 ± 0.41 10.4 ± 1.25
5 2 3 3/4 20.58 ± 2.85 11.16 ± 1.69 8.34 ± 0.52
VDSuff
1 5 2 2/4 31.95 ± 4.23 56.22 ± 2.88 28.11 ± 1.90
2 2 2 4/2 20.18 ± 2.88 17.54 ± 3.01 13.38 ± 1.51
3 2 3 3/3 18.5 ± 1.5 18.97 ± 3.56 17.98 ± 1.20
4 2 5 3/1 51.18 ± 2.59 19.46 ± 3.3 20.90 ± 3.14
5 5 3 4/1 63.79 ± 8.19 29.85 ± 2.27 15.37 ± 1.5
VDSupp
1 4 3 5/1 36.95 ± 3.48 15.78 ± 0.67 19.26 ± 1.69
2 4 4 5/1 27.54 ± 1.87 10.57 ± 2.2 9.61 ± 2.31
3 4 4 5/2 28.74 ± 1.88 11.05 ± 1.1 8.41 ± 1.81
Abbreviations: VDDef Vitamin D-deficient, VDSuff Vitamin D-sufficient, VDSupp Vitamin D-supplemented
Alcian blue, Safranin-O Fast Green, and modified Russell-Movat pentachrome staining were done for assessment of cartilage mucosubstance damage.
Immunohistochemical staining was done for aggrecans, decorins, and versicans, and the immunopositive cell density was calculated. Data are presented as
mean ± SD for immunopositive cell density. See the Methods section for discussion of cartilage grading
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suggests loss of sulfated mucosubstances of the cartilage
with decreasing vitamin D. Similarly, absence of orange to
red coloring in the VDDef group and presence of orange-
red coloring in VDSuff and VDSupp group suggest loss of
cartilage and mucinous matrix substance. In modified
Russell-Movat pentachrome staining, the VDDef group
showed more yellow coloration than the VDSuff and
VDSupp groups, while the VDSuff group showed blue-
green coloration and the VDSupp group had strong blue
coloration. The predominance of yellow coloration in
VDDef group may be due to the loss of matrix mucosub-
stance and exposure of the collagen fibrils, whereas in the
VDSuff and VDSupp groups, strong blue coloration in-
dicating the presence of matrix mucosubstance may
have masked the yellow coloration of the collagen fibers,
as they were not exposed. These results suggest the
beneficial role of vitamin D supplementation in protect-
ing the cartilage matrix by increasing matrix substance
and proteoglycans.
Inflammation and fatty infiltration may render the
muscle weak and contribute to OA [2, 6]. The architec-
tural changes or distortion of the normal architecture in
quadriceps muscles, patellar tendon, and collateral liga-
ments with the foci of inflammation and fatty infiltration
suggest that inflammation and fatty infiltration can
change the knee joint morphology in vitamin D defi-
ciency. Absence of architectural changes and fatty infil-
tration in the VDSupp group suggests the potential
beneficial role of vitamin D in decreasing inflammation
and fatty infiltration in knee joint tissues. These results
Fig. 5 Immunofluorescent staining for adiponectin and leptin in infra- and suprapatellar fat pads. Immunofluorescent staining in the vitamin
D-deficient (VDDef), vitamin D-sufficient (VDSuff), and vitamin D-supplemented (VDSupp) group infrapatellar fat is shown for adiponectin (a, d, g),
leptin (j, m, p), 4′,6-diamidino-2-phenylindole (DAPI) (b, e, h, k, n, q), merged adiponectin-DAPI (c, f, i), and merged leptin-DAPI (l, o, r). The mean
fluorescence intensity (MFI) of adiponectin and leptin with average adipocyte count (s) in infrapatellar fat, and the MFI of adiponectin and leptin
with average adipocyte count in suprapatellar fat (t), is shown for VDDef, VDSuff, and VDSupp swine. These are the representative images of five
swine each in the VDDef and VDSuff groups and three swine in the VDSupp group. Data are shown as mean ± SD. *p < 0.05, **p < 0.01
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are in accordance with those of previous studies suggest-
ing a restorative effect on muscle weakness with vitamin
D supplementation [6]. Distortion of muscle structure
may lead to muscle weakness, and it has been suggested
that muscle weakness is an early symptom of OA. Low
levels of vitamin D are associated with muscle weakness
and impaired function [41]. Muscle weakness results in
decreased shock-absorbing capacity in knee joint and
precedes and mediates cartilage degeneration [2, 42].
Our findings suggest a role for vitamin D supplementa-
tion in decreasing inflammation in tendon and ligament
in addition to its beneficial effects on muscle.
Fig. 6 Immunofluorescent staining for triggering receptor expressed on myeloid cells (TREM)-2 and macrophage (CD14) as well as colocalization of
TREM-2 with CD14+ cells in articular cartilage and synovial membrane. Immunofluorescent staining for TREM-2 (a, e, i, m, q, u), CD14 (b, f, j, n, r, v),
4′,6-diamidino-2-phenylindole (DAPI) (c, g, k, o, s, w), and merged images for examining colocalization of TREM-2 and CD14 (d, h, l, p, t, x). Arrows
indicate colocalization of TREM-2 with CD14. These are the representative images of five swine each in the vitamin D-deficient (VDDef) and vitamin
D-sufficient (VDSuff) groups and three swine in the vitamin D-supplemented (VDSupp) group
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Obesity has long been considered a risk factor for OA.
Due to the extension of the metabolic effects of obesity
to the fat depots in the knee joint, suprapatellar fat
(SPF), and infrapatellar fat (IPF), inflammation in SPF
and IPF may play a significant role in knee joint or patel-
lofemoral joint OA [43, 44]. White adipocytes acting as
endocrine cells secrete adipokines and cytokines that
regulate various functions in the human body, including
angiogenesis and the immune response [45]. Histological
analysis of knee joint tissues revealed inflammation in
IPF and SPF, mainly in VDDef swine compared with
minimal inflammation in the VDSuff group and no in-
flammation in the VDSupp group. We further stained
these tissues for the adipokines adiponectin and leptin.
Immunofluorescence studies revealed lower levels of adi-
ponectin and higher levels of leptin in the VDDef group
than in the VDSuff and VDSupp groups. Adiponectin
may play a protective role in the pathogenesis of OA by
increasing expression of tissue inhibitors of metallopro-
teinases and decreasing MMPs, and it may possess sev-
eral anti-inflammatory properties by suppressing nuclear
factor kB, interleukin 6, and tumor necrosis factor α [7].
Adiponectin levels have been considered as a biomarker
associated with early radiographic disease progression in
early rheumatoid arthritis (RA) [46]. Further, increased
adiponectin levels in synovial fluid are associated with
RA and are thought to counteract the local inflamma-
tory process [47]. Increased expression of adiponectin in
the VDSupp group in this study may also suggest a role
of vitamin D in decreasing inflammation and increasing
production of adiponectin to protect the knee joint. Fur-
ther, the role of vitamin D deficiency in other forms of in-
flammatory arthritis, such as RA, has been discussed, and
vitamin D intake has been negatively correlated with the
development of RA [48]. Increased levels of leptin are det-
rimental to chondrocytes and are associated with cartilage
degeneration and volume loss [31, 32]. In accordance with
these studies, we also found decreased adiponectin and in-
creased leptin levels in the VDDef group compared with
the VDSuff and VDSupp groups, suggesting a role of vita-
min D in enhancing adiponectin and attenuating leptin
levels, probably by decreasing inflammation.
Fatty infiltration of quadriceps muscle, patellar tendon,
and collateral ligaments was associated with increased
Fig. 7 Analysis of triggering receptor expressed on myeloid cells (TREM)-2 immunoreactivity and macrophage density. Mean fluorescence
intensity of TREM-2 (a) and number of macrophages (CD14+) (b) in the vitamin D-deficient (VDDef) (n = 5), vitamin D-sufficient (VDSuff) (n = 5),
and vitamin D-supplemented (VDSupp) (n = 3) group infrapatellar fat, muscle, articular cartilage, tendon, ligament, menisci, suprapatellar fat, and
synovial membrane. A comparative analysis was performed between the VDDef, VDSuff, and VDSupp groups. Data are shown as mean ± SD.
*p < 0.05, **p < 0.01
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inflammation in areas of fatty infiltration in the VDDef
and VDSuff groups. There was only minimal inflamma-
tion in the VDSupp group. Immunofluorescence studies
of knee joint tissues for TREM-1 and TREM-2 showed
minimal immunoreactivity for TREM-1, but, to our sur-
prise, all the tissues in the VDDef, VDSuff, and VDSupp
groups showed immunoreactivity for TREM-2, although
TREM-2 immunoreactivity was higher in the VDSupp
group than the VDDef and VDSuff groups. In agreement
with the literature which suggests that TREM-1 expres-
sion increases during inflammation [27–29], in our study
only few tissues showed TREM-1 immunoreactivity. The
high TREM-2 immunoreactivity in the VDDef group in
inflamed tissues was of interest, so we performed a dual-
immunofluorescence study of TREM-1 and TREM-2 with
macrophages and neutrophils. Dual-immunofluorescence
revealed higher number and more colocalization of mac-
rophages with TREM-2 in the VDDef group. This suggests
that higher TREM-2 expression in the presence of macro-
phages may be due to the protective response or to innate
immunity of the body. Because macrophage populations
are highly heterogeneous, changes in heterogeneity of
macrophages may play a role in OA. The lower immuno-
reactivity for TREM-1 and higher immunoreactivity for
TREM-2 also suggest a predominance of M2 macro-
phages, the anti-inflammatory macrophages, compared
Fig. 8 Immunofluorescence studies for collagen type II and matrix metalloproteinase 9 (MMP-9) in cartilage. Immunofluorescent staining is
shown for collagen II (a, d, g), MMP-9 (j, m, p), 4′,6-diamidino-2-phenylindole (DAPI) (b, e, h, k, n, q), and merged images (c, f, i, l, o, r). Mean
fluorescence intensity is shown for collagen II (s) and MMP-9 (t). These are the representative images of five swine each in the vitamin D-deficient
(VDDef) and vitamin D-sufficient (VDSuff) groups and three swine in the vitamin D-supplemented (VDSupp) group. Data are shown as mean ± SD.
**p < 0.01, ***p < 0.001
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with M1 macrophages, which are proinflammatory. The
change in heterogeneity of the macrophage plays a role in
bone remodeling or osteogenesis by changing the micro-
environment [49], but the role of heterogeneity in the
pathogenesis of OA needs to be determined. Further, the
absence of neutrophils and the presence of macrophages
only as the inflammatory cells suggest the chronicity of in-
flammation in the knee joint [50, 51] and a possible role
of macrophages in the inflammatory response. Vitamin D
may have a pleiotropic effect in immune cells, including
macrophages, and an immunomodulatory role of vitamin
D in various immune cells and diseases has been discussed
[52]. The role of vitamin D in blocking the inflammatory
cytokines, cell proliferation, and angiogenesis in the con-
text of various diseases has been studied, and potential
beneficial immunomodulatory and anti-inflammatory
roles have been elucidated [53, 54]. In this study, the
higher expression of TREM-2 in the VDSupp group sug-
gests an anti-inflammatory role of vitamin D in knee joint
tissues. The decreased colocalization of TREM-2 with
macrophages in dual-immunofluorescence studies in the
VDSupp group compared with the VDDef group further
supports the anti-inflammatory role of vitamin D. These
findings are in accordance with previous studies sug-
gesting decreased vitamin D receptor expression during
inflammation and an inflammation-attenuating effect of
vitamin D supplementation [33, 55].
Loss of cartilage volume and subchondral bone is the
primary pathophysiology of OA. Prevention of bone
damage to reduce progression of cartilage damage and
loss may reduce the severity and progression of OA [56],
and vitamin D can play an important role in attenuating
bone damage [14]. Clustering of chondrocytes in degen-
erating cartilage has been suggested as a hallmark of OA
and classified as grade 2 cartilage degeneration by the
International Cartilage Repair Society [57, 58]. Chondro-
cyte clustering is also a feature of autoimmune arthritis
(i.e., RA), where chronic inflammation does play a role
in the pathogenesis. Clustering of cells has also been
discussed in other degenerative joint diseases involving
intervertebral discs, menisci, and cricoarytenoid cartil-
age. Chondrocyte clustering may be due to the disease
progression in OA or to the increased proliferation or
migration of cells from the deeper layers [59]. In this
study, we found chondrocyte clustering (50 % of the total
chondrocytes) in the VDDef and VDSuff groups and only
3 % clustering in the VDSupp group. We also observed
that chondrocyte clustering was more prominent toward
the edges of cartilage. These data suggest that vitamin D
supplementation may have led to the decreased clustering
in the VDSupp group. As the chondrocyte clustering is
associated with cartilage degeneration, vitamin D supple-
ments may act as an intervening agent to decrease the
progression of cartilage loss. It has also been suggested
that clustered chondrocytes near degenerating cartilage
have progenitor characteristics with proliferative potential
[58]; vitamin D as a proliferative agent may thus act as an
adjunctive therapy.
Matrix degeneration occurs as a result of increased
levels of degrading enzymes, and the activity of these
metalloproteinase enzymes is modulated by vitamin D.
Low levels of vitamin D may lead to increased produc-
tion of MMPs [60]. In this study, we found increased
levels of MMP-9 expression in VDDef swine compared
with VDSuff and VDSupp swine. Further, the MMP-9
levels were higher in VDSuff swine than in VDSupp
swine. These results suggest that vitamin D supplemen-
tation attenuated the expression of MMP-9 in cartilage.
The expression of collagen II was decreased in the
VDDef group compared with the VDSuff and VDSupp
groups and in the VDSuff group compared with the
VDSupp group, which can be explained by the higher
levels of MMP-9 in VDDef and VDSuff swine. Further,
vitamin D deficiency is associated with smaller proteogly-
can monomers [61], and our results showing decreased
proteoglycans (aggrecans, decorins, and versicans) in
VDDef swine support the loss of proteoglycans in that
group. The increased expression of proteoglycans in the
VDSuff and VDSupp groups suggests a beneficial role of
vitamin D. There was uniformity of expression of matrix
substance and proteoglycans in the VDSupp group, but
the expression was nonuniform in VDSuff swine. The
higher expression of matrix substance and proteoglycans
in two swine in the VDSuff group can be explained by de-
creased aggrecan expression through its downregulation
at the posttranscriptional level with vitamin D3 [62].
Vitamin D3 may also potentiate the MMP expression in
activated chondrocytes, facilitating intrinsic chondrolysis
in the presence of proinflammatory cytokines, and it may
suppress the MMPs in activated synovial fibroblasts to de-
crease chondrolysis. Hence, vitamin D may not directly
affect the MMPs and can modulate production of other
cytokines involved in the process of chondrolysis [63].
Although serum vitamin D at baseline levels has an asso-
ciation with OA, a low vitamin D level did not predict the
loss of articular cartilage or narrowing of the joint space
[64]. However, a higher level of vitamin D has been
associated with a higher rate of hospitalization for
knee or hip joint OA [65]. Hence, there is a need to
further research the role of vitamin D in the patho-
genesis of OA.
Limitations of the study
A limitation of this study was the absence of control do-
mestic swine fed a normal diet. Another limitation may
be the small sample size in the VDSupp group. Despite
these limitations, the attenuation of inflammation and
fatty infiltration in the VDSupp group by vitamin D
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provides a new basis for further research into the role of
vitamin D in OA pathogenesis.
Conclusions
Vitamin D supplementation is associated with attenuation
of inflammation, fatty infiltration, chondrocyte clustering,
and preservation of the tissue architecture. The histo-
logical and immunofluorescence results of the present
study are closely related and thus validate the microscopic
findings. The results of this study demonstrate the poten-
tial beneficial effect of vitamin D in decreasing inflamma-
tion and fatty infiltration in knee joints, which may
decrease pain and disability. However, the role of vitamin
D supplementation in decreasing the progression of cartil-
age loss or OA needs to be investigated.
Additional files
Additional file 1: Table S2. Baseline table for swine groups. The study
included a total of 13 swine: 5 in the VDDef group, 5 in the VDSuff
group, and 3 in the VDSupp group. Weight is indicated in pounds (lb).
Average vitamin D3 levels were measured after 1 year of vitamin D diet
intervention. Chondrocyte clustering was measured at × 40 magnification.
(DOCX 13 kb)
Additional file 2: Table S3. Overview of all tissues with regard to
inflammation and fatty infiltration. Inflammation in knee joint tissues
(suprapatellar fat, infrapatellar fat, muscle, tendon, ligament, and menisci)
was subjectively graded on the basis of the following criteria: nil = no
inflammation; 1+ = occasional inflammatory cells; 2+ = few inflammatory
cells; 3+ =many inflammatory cells; and 4+ = clumps or clusters of
inflammatory cells. Macrophage density was calculated for inflammation
in cartilage of all knee joints. Macrophage density (CD14+ cells) in all the
knee joint tissues was analyzed for objective grading of inflammation
(Fig. 6). Subjective grading of fatty infiltration was based on the following
criteria: no fatty infiltration; minimal fatty infiltration = fatty infiltration in
up to 5 % of tissue area; mild fatty infiltration = fatty infiltration in 6–25 %
of tissue area; moderate fatty infiltration = fatty infiltration in 25–50 % of
tissue area; and severe fatty infiltration = fatty infiltration in >50 % of
tissue area. Further, the percentage of fatty infiltration was calculated
(Fig. 2). (DOCX 16 kb)
Additional file 3: Figure S9. Immunofluorescent staining for adiponectin
and leptin in suprapatellar fat pad. Immunofluorescent staining in the VDDef,
VDSuff, and VDSupp suprapatellar fat pads for adiponectin (a, d, and g), leptin
(j,m, and p), DAPI (b, e, h, k, n, and q), merged adiponectin-DAPI (c, f, and i),
and merged leptin-DAPI (l, o, and r). These are the representative images of
five swine each in the VDDef and VDSuff groups and three swine in the
VDSupp group. (TIF 91287 kb)
Additional file 4: Figure S10. Immunofluorescent staining for TREM-2
and macrophage (CD14) and colocalization of TREM-2 with CD14+ cells
in infrapatellar fat and muscle. Immunofluorescent staining for TREM-2
(a, e, i, m, q, and u), CD14 (b, f, j, n, r, and v), and DAPI (c, g, k, o, s,
and w) was performed, and stains were merged to examine colocalization
of TREM-2 and CD14 (d, h, l, p, t, and x). Arrows show the colocalization of
TREM-2 with CD14. These are the representative images of five swine each
in the VDDef and VDSuff groups and three swine in the VDSupp group.
(TIF 159298 kb)
Additional file 5: Figure S11. Immunofluorescent staining for TREM-2
and macrophage (CD14) as well as colocalization of TREM-2 with CD14+
cells in tendon and ligament. Immunofluorescent staining for TREM-2
(a, e, i, m, q, and u), CD14 (b, f, j, n, r, and v), and DAPI (c, g, k, o, s,
and w) was performed, and stains were merged to examine colocalization
of TREM-2 and CD14 (d, h, l, p, t, and x). Arrows show the colocalization of
TREM-2 with CD14. These are the representative images of five swine each
in the VDDef and VDSuff groups and three swine in the VDSupp group.
(TIF 157582 kb)
Additional file 6: Figure S12. Immunofluorescent staining for TREM-2
and macrophage (CD14) and for colocalization of TREM-2 with CD14+ cells
in menisci and suprapatellar fat. Immunofluorescent staining for TREM-2
(a, e, i, m, q, and u), CD14 (b, f, j, n, r, v), and DAPI (c, g, k, o, s, and w) was
performed, and stains were merged to examine colocalization of TREM-2
and CD14 (d, h, l, p, t, and x). Arrows show the colocalization of TREM-2 with
CD14. These are the representative images of five swine each in the VDDef
and VDSuff groups and three swine in the VDSupp group. (TIF 157634 kb)
Additional file 7: Figure S13. Immunofluorescent staining for TREM-1
and macrophage (CD14) and for colocalization of TREM-1 with CD14+ cells in
articular cartilage, tendon, ligament, and suprapatellar fat. Immunofluorescent
staining for TREM-1 (a, e, i, and m), CD14 (b, f, j, and n), and DAPI (c, g, k,
and o) was performed, and stains were merged to examine colocalization
of TREM-1 and CD14 (d, h, l, and p). Arrows show the colocalization of
TREM-1 with CD14. These are the representative images of five swine each
in the VDDef and VDSuff groups and three swine in the VDSupp group.
(TIF 107810 kb)
Additional file 8: Figure S14. Immunofluorescent staining for collagen
types I, II, and III in articular cartilage. Immunofluorescent staining for
collagen I (a), collagen II (d), collagen III (g), and DAPI (b, e, and h).
Merged images are also shown (c, f, and i). These are the representative
images of five swine each in the VDDef and VDSuff groups and three
swine in the VDSupp group. (TIF 79516 kb)
Additional file 9: Figure S15. Immunofluorescent staining for MMPs 1,
2, 8, 9, and 13 in articular cartilage. Immunofluorescent staining for MMP-1
(a), MMP-2 (d), MMP-8 (g), MMP-9 (j), MMP-13 (m), and DAPI (b, f, h, k, n,
and q), as well as merged images (c, f, i, l, o, and r), are shown. These are
the representative images of five swine each in the VDDef and VDSuff
groups and three swine in the VDSupp group. (TIF 75620 kb)
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